American Society of Hematology

SHERPA: Blue

People

  1. Levine
    Levine
  2. Rampal
    Rampal
  3. Tallman
    Tallman
  4. Stein
    Stein
  5. Scheinberg
    Scheinberg
  6. Abdel-Wahab
    Abdel-Wahab
  7. Park
    Park
  8. Mauro
    Mauro
  9. Goldberg
    Goldberg
  10. Berman
    Berman

Groups

  1. Adult Leukemia (1288)
  2. Center for Hematologic Malignancies (1288)
  3. Department of Medicine (1288)
  4. Hematologic Malignancies, Division of (1288)
  5. GSK Faculty (579)
  6. Executive Committee, Center for Hematologic Malignancies (387)
  7. Human Oncology and Pathogenesis Program (325)
  8. Center for Molecular Imaging and Biotechnology (303)
  9. Tow Center for Developmental Oncology (TCDO) (278)
  10. Hematologic Malignancies Research (228)
Search Within
  1. "Adult Leukemia"
Formats
  1. Meeting Abstract (986)
  2. Journal Article (276)
  3. Research Letter (11)
  4. Review (10)
  5. Editorial (3)
  6. Guidelines (2)
Groups
  1. Adult Leukemia (1288)
  2. Center for Hematologic Malignancies (1288)
  3. Department of Medicine (1288)
  4. Hematologic Malignancies, Division of (1288)
  5. GSK Faculty (579)
  6. Executive Committee, Center for Hematologic Malignancies (387)

More Groups

People
  1. Ross Levine (312)
  2. Martin Tallman (298)
  3. Eytan Stein (169)
  4. Raajit Rampal (154)
  5. Jae Park (146)
  6. David Scheinberg (121)

More People

Years
  1. 2025 (8)
  2. 2024 (55)
  3. 2023 (104)
  4. 2022 (100)
  5. 2021 (92)
  6. 2020 (85)

More Years

Publications
  1. Blood (1200)
  2. Blood Advances (76)
  3. Hematology-American Society of Hematology Education Program (12)

Results (1288)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clonotype-immunophenotype relationships in TET2 and IDH-mutant myeloid transformation
    Meeting Abstract

    Miles, L. A.; Bowman, R. L.; Delgaudio, N.; Robinson, T.; Carroll, M. P.; Meyer, S. E.; Levine, R. L.
    Blood (2021)

    Fulltext@MSK | Save
  • Real-world treatment patterns and outcomes of patients with chronic lymphocytic leukemia (CLL) receiving first-line (1L) therapy in the United States (US)
    Meeting Abstract

    Mato, A. R.; Ravelo, A.; To, T. M; Schuldt, R.; Biondo, J. M. L.
    Blood (2021)

    Fulltext@MSK | Save
  • Pirtobrutinib, a next generation, highly selective, non-covalent BTK inhibitor in previously treated CLL/SLL: Updated results from the phase 1/2 BRUIN study
    Meeting Abstract

    Mato, A. R.; Pagel, J. M.; Coombs, C. C.; Shah, N. N.; Lamanna, N.; Munir, T.; Lech-Maranda, E.; Eyre, T. A.; Woyach, J. A.; Wierda, W. G.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Safety analysis of pacritinib in patients with myelofibrosis and severe thrombocytopenia
    Meeting Abstract

    Mascarenhas, J.; Harrison, C. N.; Gerds, A. T.; Prchal, J. T.; Rampal, R.; Buckley, S. A.; Craig, A. R.; Smith, J. A.; Volpone, J.; Roman-Torres, K.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Treatment of myelofibrosis patients with the TGF-β 1/3 inhibitor AVID200 (MPN-RC 118) induces a profound effect on platelet production
    Meeting Abstract

    Mascarenhas, J.; Kosiorek, H. E.; Bhave, R.; Palmer, J. M.; Kuykendall, A. T.; Mesa, R. A.; Rampal, R.; Gerds, A. T.; Yacoub, A.; Pettit, K. M.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Phase I first-in-class trial of MCARH109, a G protein coupled receptor class C group 5 member D (GPRC5D) targeted CAR T cell therapy in patients with relapsed or refractory multiple myeloma
    Meeting Abstract

    Mailankody, S.; Diamonte, C.; Fitzgerald, L.; Kane, P.; Wang, X.; Sikder, D. S.; Senechal, B.; Bermudez, V. P.; Frias, D.; Morgan, J.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Targeting PRAME with TCR-mimic CAR T cells in AML
    Meeting Abstract

    Loeb, A. M.; Castro, S.; Nourigat-Mckay, C.; Perkins, L.; Pardo, L.; Leonti, A. R.; Tang, T. T.; Call, L. F.; Hylkema, T. A.; Scheinberg, D. A.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • HMGA1 chromatin regulators drive progression in myeloproliferative neoplasms through epigenetic rewiring to induce networks involved in GATA2 and proliferation
    Meeting Abstract

    Li, L.; Kim, J. H.; Lu, W.; Cope, L.; Williams, D. M.; Kim, J.; Rampal, R.; Koche, R.; Xian, L.; Luo, L.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • The BMP/SMAD pathway is a key mediator of leukemic transformation of TP53-mutant post-MPN AML
    Meeting Abstract

    Li, B.; An, W.; Wang, H.; Krishnan, A.; Mowla, S.; Baslan, T.; Koche, R.; Xiao, W.; Lowe, S.; Levine, R. L.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Pelabresib (CPI-0610) monotherapy in patients with myelofibrosis - Update of clinical and translational data from the ongoing MANIFEST trial
    Meeting Abstract

    Kremyanskaya, M.; Mascarenhas, J.; Palandri, F.; Vannucchi, A.; Verstovsek, S.; Harrison, C. N.; Bose, P.; Schiller, G. J.; Rampal, R.; Drummond, M. W.; more...
    Blood (2021)

    Fulltext@MSK | Save